Protective effect of the peroxisome proliferator-activated receptor (PPAR)-γ, ligand rosiglitazone on tert-butyl hydroperoxide-induced QZG cell injury

Experimental and Toxicologic Pathology

Volumn 63, Issue 6, 2011, Pages 527-533

  Li, Wen Li ^a   Liang, Xin ^a   Wang, Xin ^a   Zhang, Xiao Di ^a   Liu, Rui ^a   Zhang, Wei ^a   Chen, Hong Li ^a   Qin, Xu Jun ^a   Bai, Hua ^a   Hai, Chun Xu ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell injury; Oxidative stress; Rosiglitazone; Tert Butyl hydroperoxide

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; TERT BUTYL HYDROPEROXIDE;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL DEATH; CELL PROTECTION; CELL SHAPE; CELL STRUCTURE; CELL VIABILITY; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; ELECTRON MICROSCOPY; EUKARYOTIC FLAGELLUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MICROSCOPY; MITOCHONDRION SWELLING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANTIOXIDANTS; CELL CULTURE TECHNIQUES; CELL LINE; CELL SURVIVAL; DATA INTERPRETATION, STATISTICAL; FLOW CYTOMETRY; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, PHASE-CONTRAST; OXIDATIVE STRESS; PPAR GAMMA; TERT-BUTYLHYDROPEROXIDE; THIAZOLIDINEDIONES;

EID: 80051687247     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2010.04.003     Document Type: Article

References (35)

1. Abdelrahman M., Sivarajah A., Thiemermann C. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock. Cardiovasc Res 2005, 65:772-781.
2. Akhori T., Sho M., Hamada K., suzaki Y., Kuzumoto Y., Nomi T., et al. Importance of peroxisome proliferator activated receptors-γin hepatic ischemia/reperfusion injury in mice. J Hepatol 2007, 47:784-792.
3. Aoun P. Role of PPAR-g ligands in neuroprotection. Invest Ophthalmol Vis Sci 2003, 44:2999-3004.
4. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997, 272:20313-20316.
5. Chen K., Li D., Zhang X., Hermonat P.L., Mehta J.L. Anoxiareoxygenation stimulates collagen type-I and MMP-1 expression in cardiac fibroblasts: modulation by the PPAR-gamma ligand pioglitazone. J Cardiovasc Pharmacol 2004, 44:682-687.
6. Chen Z.H., Yoshida Y., Saito Y., Sekine A., Noguchi N., Niki E. Induction of adaptive response and enhancement of PC12 cell tolerance by 7-hydroxycholesterol and 15-deoxy-D12,14-prostaglandin J2 through upregulation of cellular glutathione via different mechanisms. J Biol Chem 2006, 281:14440-14445.
7. Cuzzocrea S., Pisano B., Dugo L., Ianaro A., Mafia P., Patel N.S.A. Rosiglitazone, a ligand of the peroxisome proliferator activated receptor-g reduces acute inflammation. Eur J Pharmacol 2004, 483:79-93.
8. Dobrian A.D., Schriver S.D., Khraibi A.A., Prewitt R.L. Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity. Hypertension 2004, 43:48-56.
9. Fajas L., Auboeuf D., Raspe E., Schoonjans K., Lefebvre A.M., Salsadin R., et al. The organization, promoter analysis, and expression of the human PPARγ gene. J Biol Chem 1997, 272:18779-18789.
10. Gillies P.S., Dunn C.J. Pioglitazone. Drugs 2000, 60:333-343.
11. Han S., Roman J. Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?. Anticancer Drugs 2007, 18:237-244.
12. Imberti R., Nieminen A.L., Herman B., Lemasters J.J. Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: protection by fructose, cyclosporin A and trifluoperazine. J Pharmacol Exp Ther 1993, 265:392-400.
13. Jowsey I.R., Smith S.A., Hayes J.D. Expression of the murine glutathione S-transferase alpha3 (GSTA3) subunit is markedly induced during adipocyte differentiation: activation of the GSTA3 gene promoter by the proadipogenic eicosanoid 15-deoxy-D12, 14-prostaglandin J2. Biochem Biophys Res Commun 2003, 312:1226-1235.
14. Kielian T., Drew P.D. Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation. J Neurosci Res 2003, 71:315-325.
15. Kuboki S., Shin T., Huber N., Eismann T., Galloway E., Schuster R., et al. Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. Hepatology 2008, 47(1):215-224.
16. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995, 270:12953-12956.
17. Lenhard M.J., Funk W.B. Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis. Diabetes Care 2001, 24:168-169.
18. Lim S.-Y., Jang J.-H., Na H.-K., Lu S.C., Rahman I., Surh Y.-J. 15-Deoxy-D12,14-prostaglandin J2 protects against nitrosative PC12 cell death through upregulation of intracellular glutathione synthesis. J Biol Chem 2004, 279:46263-46270.
19. Liu D., Zeng B.X., Zhang S.H., Yao S.L. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia. Inflamm Res 2005, 54:464-470.
20. Lotkova H., Cervinkova Z., Kucera O., Krivakova P., Kandar R. Protective effect of S-adenosylmethionine on cellular and mitochondrial membranes of rat hepatocytes against tert-butylhydroperoxide-induced injury in primary culture. Chem Biol Interact 2005, 156:13-23.
21. Mehta J.L., Hu B., Chen J., Li D. Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation. Arterioscler Thromb Vasc Biol 2003, 23:2203-2208.
22. ® Green I technology. Rapid Cycle Real-time PCR, Methods and Applications 2001, 281-291. Springer, Heidelberg. S. Meuer, C. Wittwer, K. Nakagawara (Eds.).
23. Sanches-Hidalgo M., Martin A.R., Villegas I., Alarcon De La Lastra C. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in a rats. Biochem Pharmacol 2005, 69:733-744.
24. Sener G., Sehirli A.O., Gedik N., Dulger G.A. Rosiglitazone, PPAR-g ligand, protects against burn-induced oxidative injury of remote organs. Burns 2007, 33:587-593.
25. Sertznig P., Seifert M., Tilgen W., Reichrath J. Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer. J Cell Physiol 2007, 212:1-12.
26. Staels B., Schoonjans K., Fruchart J.C., Auwerx J. The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs). Biochemie 1997, 79:95-99.
27. Villegas I., Martin A.R., Toma W., de la Lastra C.A. Rosiglitazone, an agonist of peroxisome proliferators activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation. Eur J Pharmacol 2004, 28:195-203.
28. Ward P.A. Mechanisms of endothelial cell injury. J Lab Clin Med 1991, 118:421-426.
29. Watkins P.B., Whitcomb R.W. Hepatic dysfunction associated with troglitazone. N Engl J Med 1998, 338:916-917.
30. Willson T.M., Cobb J.E., Cowan D.J., Wiethe R.W., Correa I.D., Prakash S.R., et al. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem 1996, 39:665-668.
31. Wu J.S., Lin T.N., Wu K.K. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins. J Cell Physiol 2009, 220:58-71.
32. Yi J.-H., Park S.-W., Brooks N., Langa B.T., Vemuganti R. PPARγ agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms. Brain Research. 2008, 1244:164-172.
33. Yki-Jarvinen H. Thiazolidinediones. N. Engl. J. Med. 2004, 351:1106-1118.
34. Zhang Q.W., Seltmann H., Zouboulis C.C., Konger R.L. Involvement of PPARc in oxidative stress-mediated prostaglandin E2 production in SZ95 human sebaceous gland cells. J Invest Dermatol 2006, 126:42-48.
35. Zhuang H., Kim Y.S., Namiranian K., Dore S. Prostaglandins of J series control heme oxygenase expression: potential significance in modulating neuroinflammation. Ann NY Acad Sci 2003, 993:208-216.